Statera Biopharma [STAB] - Last Close: $0.1402
Statera Bio is surging after landing a key patent.
Yesterday, the biotech firm gained 7% on news it was granted European patent number EP2306708 titled "Methods And Compositions For The Treatment Of Radiation-related Disorders"
Shares rallied again in the premarket after the company's Form 10K filing hit the market this morning.
It's unclear what specific part of the lengthy filing sparked the rally, but the document included details on the company's financial status, drug pipeline, clinical updates, and more.
Whatever it was, investors liked what they saw, and STAB is one of this morning's top performers with a 75.4% gain on active trading volume.
My Take: STAB isn't exhibiting the typical signs you see with a short squeeze, so I don't think that's what's driving this move. However, it's not hard to move share prices with a market cap of only $7.01 million, so there could be some targeted manipulation at play here.
Green Giant Inc. [GGE] - Last Close: $0.70
Chinese property developer Green Giant is moving higher today.
The stock is rebounding after a brutal stretch of losses that chopped down share prices to less than one-fifth of their 52-week highs of $3.80.
Rumors of trouble with the Chinese economy and concerns over the fiscal health of fellow Chinese property developer Evergrande Inc soured investor sentiment towards GGE and sparked the stock's row of losses.
However, the sell-off could be finally bottoming out, as GGE is showing sharp gains in today's premarket despite little to no news to explain the move.
GGE is up 60.0% on active premarket trading volume.
My Take: Chinese stocks can be very volatile, and the region isn't exactly a stranger to unscrupulous accounting practices. There could be opportunities for some short-term gains in this stock, but be ready to make a quick exit if needed.
